Sharecare Blog
Blog
Actions
Media Outlet details
| Scope | National |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesMigraines with Aura and Migraines Without Aura
Medically reviewed in December 2020 Migraine is a disorder that causes recurring episodes of headaches and other symptoms. Most migraines fall into one of two categories: Migraine without aura, also known as a common migraine. Migraine with aura, also known as a classic migraine.
The Center for Global Health Innovation launches innovation district in 47-story tower in Midtown Atlanta
District’s launch enabled by strategic partnerships across philanthropic and industry leaders, including Sharecare, Transwestern and anonymous West Coast foundation ATLANTA – Dec.
Dr. Randy Shemer, DO
Breaking the Stigma: 13 Essential Facts About HIV/AIDS In 1981, a group of researchers and scientists published a report in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report (MMWR) about cases of an uncommon type of pneumonia in gay men. Whether the researchers of that... Read More
Understanding and Treating Tardive Dyskinesia
Dr. Sue Varma and Dr. Sanjay Gupta talk about Tardive Dyskinesia: what it looks like, who gets it, and how to treat TD.
Sharecare and UCB to present on future of decentralized clinical research at 2021 CNS Summit
Spotlight session highlighting Sharecare’s efforts to advance real-world relevance, equity, and data integrity in clinical research scheduled for Monday, Nov. 8 at 2 p.m. EST ATLANTA – Nov. 3, 2021 – Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that it will co-present with global biopharmaceutical company UCB at the 12th annual CNS Summit on Monday, Nov. 8 at 2:00 p.m. EST.
Scientists Developing Vaccine to Prevent Deadly Form of Breast Cancer
By Jenny Blair, MD Medically reviewed in November 2021 Updated on November 1, 2021 A rare and deadly form of breast cancer may one day be a vaccine-preventable disease. Researchers at the Cleveland Clinic are testing an innovative vaccine that could stop a deadly form of breast cancer just as it starts. They’ve launched an early-phase trial of an experimental vaccine against triple-negative breast cancer, an uncommon type of breast cancer that is hard to treat and often lethal.
The Wellness Hack That Health Experts Actually Swear By
By Casey Gueren Medically reviewed in October 2021 Updated on October 28, 2021 What if I told you there was an amazing health hack that can add years to your life, is evidence-based, and that doctors actually swear by? Sure, it costs some money and requires a bit of work, but so do all those other wellness fads you’ve tried over the years. Okay, ready for the hack? It’s basic preventive care.
Sharecare’s Dr. Nirav R. Shah named to Advisory Committee to CDC Director
Panel of experts offers professional, technical recommendations to support CDC’s mission ATLANTA – October 25, 2021 – Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that its chief medical officer, Nirav R. Shah, MD, MPH, has accepted an invitation to join the Advisory Committee to the Director of the Centers for Disease Control and Prevention (ACD).
Will an Antibody Test Reveal If You’re Immune to COVID-19?
By Jenny Blair, MD Medically reviewed in November 2021 Updated on November 10, 2021 Nearly two years into the coronavirus pandemic, millions of Americans got their COVID shots months ago. If you were vaccinated early on, you might be wondering if the vaccine really worked—and if it did, whether you are still protected months later. Rest assured, based on efficacy data that continues to be collected, all three of the available vaccines protect the vast majority of people very well.
Johnson & Johnson COVID Booster Gets a Green Light from CDC
By Jenny Blair, MD Medically reviewed in October 2021 Updated on October 21, 2021 Americans eligible for a COVID booster now have three options available to them, including the Johnson & Johnson (J&J) vaccine. The Centers for Disease Control and Prevention (CDC) approved the FDA’s decision to authorize a booster for all J&J recipients ages 18 and older who got the jab at least 2 months ago.